{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:49:03Z","timestamp":1791514143771,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Program of Heilongjiang","award":["2022ZX06C11"],"award-info":[{"award-number":["2022ZX06C11"]}]},{"name":"the Nn10 Program of Harbin Medical University Cancer Hospital","award":["Nn10pv2017-04"],"award-info":[{"award-number":["Nn10pv2017-04"]}],"id":[{"id":"https:\/\/ror.org\/01f77gp95","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01261-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:24:30Z","timestamp":1784121870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA-binding protein RALYL-mediated BCL11B RNA stability promotes immune escape in small cell lung cancer through transcriptional activation of BUB3"],"prefix":"10.1007","volume":"49","author":[{"given":"Jiayue","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-8181","authenticated-orcid":false,"given":"Qingwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"1","key":"1261_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"C.M. Rudin, E. Brambilla, C. Faivre-Finn et al., Small-cell lung cancer. Nat. Rev. Dis. Primers. 7(1), 3 (2021). https:\/\/doi.org\/10.1038\/s41572-020-00235-0","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"1261_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3322\/caac.21785","volume":"73","author":"Z Megyesfalvi","year":"2023","unstructured":"Z. Megyesfalvi, C.M. Gay, H. Popper et al., Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. CA Cancer J. Clin. 73(6), 620\u2013652 (2023). https:\/\/doi.org\/10.3322\/caac.21785","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"1261_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/cbin.11359","volume":"44","author":"Y Wang","year":"2020","unstructured":"Y. Wang, S. Zou, Z. Zhao et al., New insights into small-cell lung cancer development and therapy. Cell. Biol. Int. 44(8), 1564\u20131576 (2020). https:\/\/doi.org\/10.1002\/cbin.11359","journal-title":"Cell. Biol. Int."},{"issue":"3","key":"1261_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","volume":"9","author":"WJ Petty","year":"2023","unstructured":"W.J. Petty, L. Paz-Ares, Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review. JAMA Oncol. 9(3), 419\u2013429 (2023). https:\/\/doi.org\/10.1001\/jamaoncol.2022.5631","journal-title":"JAMA Oncol."},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"R. Rui, L. Zhou, S. He, Cancer immunotherapies: advances and bottlenecks. Front. Immunol. 14, 1212476 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1212476","journal-title":"Front. Immunol."},{"key":"1261_CR6","doi-asserted-by":"publisher","first-page":"581674","DOI":"10.3389\/fcell.2020.581674","volume":"8","author":"MT Daher","year":"2020","unstructured":"M.T. Daher, P. Bausero, O. Agbulut et al., Bcl11b\/Ctip2 in Skin, Tooth, and Craniofacial System. Front. Cell. Dev. Biol. 8, 581674 (2020). https:\/\/doi.org\/10.3389\/fcell.2020.581674","journal-title":"Front. Cell. Dev. Biol."},{"key":"1261_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fncel.2017.00089","volume":"11","author":"MJ Lennon","year":"2017","unstructured":"M.J. Lennon, S.P. Jones, M.D. Lovelace et al., Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease. Front. Cell. Neurosci. 11, 89 (2017). https:\/\/doi.org\/10.3389\/fncel.2017.00089","journal-title":"Front. Cell. Neurosci."},{"issue":"12","key":"1261_CR8","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1172\/JCI126350","volume":"129","author":"M Maluski","year":"2019","unstructured":"M. Maluski, A. Ghosh, J. Herbst et al., Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development. J. Clin. Invest. 129(12), 5108\u20135122 (2019). https:\/\/doi.org\/10.1172\/JCI126350","journal-title":"J. Clin. Invest."},{"key":"1261_CR9","doi-asserted-by":"publisher","first-page":"669498","DOI":"10.3389\/fimmu.2021.669498","volume":"12","author":"T Sidwell","year":"2021","unstructured":"T. Sidwell, E.V. Rothenberg, Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b. Front. Immunol. 12, 669498 (2021). https:\/\/doi.org\/10.3389\/fimmu.2021.669498","journal-title":"Front. Immunol."},{"key":"1261_CR10","doi-asserted-by":"publisher","unstructured":"P.M.A. Silva, H. Bousbaa, BUB3, beyond the simple role of partner. Pharmaceutics. 14(5), (2022). https:\/\/doi.org\/10.3390\/pharmaceutics14051084","DOI":"10.3390\/pharmaceutics14051084"},{"issue":"5","key":"1261_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/cbin.11740","volume":"46","author":"C Wang","year":"2022","unstructured":"C. Wang, D. Cheng, C. Pan et al., Research progress of Bub3 gene in malignant tumors. Cell. Biol. Int. 46(5), 673\u2013682 (2022). https:\/\/doi.org\/10.1002\/cbin.11740","journal-title":"Cell. Biol. Int."},{"key":"1261_CR12","doi-asserted-by":"publisher","unstructured":"Q. Ye, N.L. Guo, Hub genes in non-small cell lung cancer regulatory networks. Biomolecules. 12(12), (2022). https:\/\/doi.org\/10.3390\/biom12121782","DOI":"10.3390\/biom12121782"},{"issue":"1","key":"1261_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12967-023-04373-3","volume":"21","author":"J Ma","year":"2023","unstructured":"J. Ma, L. Sun, W. Gao et al., RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors. J. Transl Med. 21(1), 512 (2023). https:\/\/doi.org\/10.1186\/s12967-023-04373-3","journal-title":"J. Transl Med."},{"issue":"1","key":"1261_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"H. Qin, H. Ni, Y. Liu et al., RNA-binding proteins in tumor progression. J. Hematol. Oncol. 13(1), 90 (2020). https:\/\/doi.org\/10.1186\/s13045-020-00927-w","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"1261_CR15","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1093\/oncolo\/oyad193","volume":"28","author":"Y Wei","year":"2023","unstructured":"Y. Wei, L. Zheng, X. Yang et al., Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer. Oncologist. 28(11), e1052\u2013e64 (2023). https:\/\/doi.org\/10.1093\/oncolo\/oyad193","journal-title":"Oncologist"},{"issue":"1","key":"1261_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41420-022-00922-9","volume":"8","author":"H Guo","year":"2022","unstructured":"H. Guo, Y. Xiao, Z. Yuan et al., Inhibition of STAT3(Y705) phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells. Cell. Death Discov. 8(1), 116 (2022). https:\/\/doi.org\/10.1038\/s41420-022-00922-9","journal-title":"Cell. Death Discov"},{"issue":"20","key":"1261_CR17","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","volume":"28","author":"JB Hiatt","year":"2022","unstructured":"J.B. Hiatt, H. Sandborg, S.M. Garrison et al., Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing. Clin. Cancer Res. 28(20), 4551\u20134564 (2022). https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1128","journal-title":"Clin. Cancer Res."},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"1157397","DOI":"10.3389\/fimmu.2023.1157397","volume":"14","author":"T Daunke","year":"2023","unstructured":"T. Daunke, S. Beckinger, S. Rahn et al., Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma. Front. Immunol. 14, 1157397 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1157397","journal-title":"Front. Immunol."},{"key":"1261_CR19","doi-asserted-by":"publisher","unstructured":"Q. Dong, T. Yu, B. Chen et al., Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS\/STING pathway. JCI Insight. 8(21), (2023). https:\/\/doi.org\/10.1172\/jci.insight.165268","DOI":"10.1172\/jci.insight.165268"},{"issue":"1","key":"1261_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-023-02862-3","volume":"42","author":"M Liang","year":"2023","unstructured":"M. Liang, Z. Sun, X. Chen et al., E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells. J. Exp. Clin. Cancer Res. 42(1), 275 (2023). https:\/\/doi.org\/10.1186\/s13046-023-02862-3","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"1261_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/JTO.0000000000000562","volume":"10","author":"L Zhang","year":"2015","unstructured":"L. Zhang, H. Yu, A. Badzio et al., Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer. J. Thorac. Oncol. 10(7), 1083\u20131090 (2015). https:\/\/doi.org\/10.1097\/JTO.0000000000000562","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"1261_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41598-025-85471-8","volume":"15","author":"B Wang","year":"2025","unstructured":"B. Wang, Y. Yin, A. Wang et al., SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma. Sci Rep. 15(1), 1640 (2025). https:\/\/doi.org\/10.1038\/s41598-025-85471-8","journal-title":"Scientific Reports"},{"issue":"4","key":"1261_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bjc.6690745","volume":"81","author":"L Drivsholm","year":"1999","unstructured":"L. Drivsholm, L.I. Paloheimo, K. Osterlind, A. Chromogranin, a significant prognostic factor in small cell lung cancer. Br. J. Cancer. 81(4), 667\u2013671 (1999). https:\/\/doi.org\/10.1038\/sj.bjc.6690745","journal-title":"Br. J. Cancer"},{"issue":"1","key":"1261_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41420-021-00520-1","volume":"7","author":"YC Chang","year":"2021","unstructured":"Y.C. Chang, M.H. Chan, C.H. Li et al., Metabolic protein phosphoglycerate kinase 1 confers lung cancer migration by directly binding HIV Tat specific factor 1. Cell. Death Discov. 7(1), 135 (2021). https:\/\/doi.org\/10.1038\/s41420-021-00520-1","journal-title":"Cell. Death Discov"},{"key":"1261_CR25","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.2147\/OTT.S210223","volume":"12","author":"L He","year":"2019","unstructured":"L. He, Y. Li, X. Huang et al., The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer. Onco Targets Ther. 12, 5897\u20135906 (2019). https:\/\/doi.org\/10.2147\/OTT.S210223","journal-title":"Onco Targets Ther."},{"issue":"4","key":"1261_CR26","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3892\/mmr.2017.7095","volume":"16","author":"Y Xu","year":"2017","unstructured":"Y. Xu, Z. Liang, C. Li et al., LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells. Mol. Med. Rep. 16(4), 4159\u20134164 (2017). https:\/\/doi.org\/10.3892\/mmr.2017.7095","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"1261_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2015.05.023","volume":"365","author":"D Douchi","year":"2015","unstructured":"D. Douchi, H. Ohtsuka, K. Ariake et al., Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt\/beta-catenin signaling pathway. Cancer Lett. 365(1), 132\u2013140 (2015). https:\/\/doi.org\/10.1016\/j.canlet.2015.05.023","journal-title":"Cancer Lett."},{"issue":"3","key":"1261_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41435-024-00263-w","volume":"25","author":"JM Garcia-Aznar","year":"2024","unstructured":"J.M. Garcia-Aznar, S. Alonso Alvarez, T. Bernal Del Castillo, Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective. Genes Immun. 25(3), 232\u2013241 (2024). https:\/\/doi.org\/10.1038\/s41435-024-00263-w","journal-title":"Genes Immun."},{"key":"1261_CR29","doi-asserted-by":"publisher","first-page":"1297363","DOI":"10.3389\/fimmu.2023.1297363","volume":"14","author":"X Sui","year":"2023","unstructured":"X. Sui, G. Wu, Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes. Front. Immunol. 14, 1297363 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1297363","journal-title":"Front. Immunol."},{"issue":"14","key":"1261_CR30","doi-asserted-by":"publisher","first-page":"15650","DOI":"10.1002\/cam4.6167","volume":"12","author":"H Abe","year":"2023","unstructured":"H. Abe, K. Kamimura, S. Okuda et al., BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis. Cancer Med. 12(14), 15650\u201315663 (2023). https:\/\/doi.org\/10.1002\/cam4.6167","journal-title":"Cancer Med."},{"issue":"1","key":"1261_CR31","doi-asserted-by":"publisher","first-page":"e1928","DOI":"10.1002\/wnan.1928","volume":"16","author":"X Li","year":"2024","unstructured":"X. Li, G. Chen, K. Wu et al., Imaging and monitoring of granzyme B in the immune response. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 16(1), e1928 (2024). https:\/\/doi.org\/10.1002\/wnan.1928","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"issue":"1","key":"1261_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s12885-024-12363-x","volume":"24","author":"Y Hayashi","year":"2024","unstructured":"Y. Hayashi, A. Ueyama, S. Funaki et al., In situ analysis of CCR8(+) regulatory T cells in lung cancer: suppression of GzmB(+) CD8(+) T cells and prognostic marker implications. BMC Cancer. 24(1), 627 (2024). https:\/\/doi.org\/10.1186\/s12885-024-12363-x","journal-title":"BMC Cancer"},{"issue":"4","key":"1261_CR33","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.isci.2021.102307","volume":"24","author":"TT Drashansky","year":"2021","unstructured":"T.T. Drashansky, E.Y. Helm, N. Curkovic et al., BCL11B is positioned upstream of PLZF and RORgammat to control thymic development of mucosal-associated invariant T cells and MAIT17 program. iScience. 24(4), 102307 (2021). https:\/\/doi.org\/10.1016\/j.isci.2021.102307","journal-title":"iScience"},{"key":"1261_CR34","doi-asserted-by":"publisher","unstructured":"Y. Kui, F. Tong, R. Zhang et al., Strategies to target PD-1\/PD-L1 in the tumor microenvironment. Cell. Oncol. (Dordr). 49(2), (2026). https:\/\/doi.org\/10.1007\/s13402-026-01181-x","DOI":"10.1007\/s13402-026-01181-x"},{"issue":"1","key":"1261_CR35","doi-asserted-by":"publisher","first-page":"2148850","DOI":"10.1080\/2162402X.2022.2148850","volume":"11","author":"H Forkel","year":"2022","unstructured":"H. Forkel, P. Grabarczyk, M. Depke et al., BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood alphabeta CD8\u2009+\u2009T cells. Oncoimmunology. 11(1), 2148850 (2022). https:\/\/doi.org\/10.1080\/2162402X.2022.2148850","journal-title":"Oncoimmunology"},{"issue":"3","key":"1261_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.18632\/aging.204517","volume":"15","author":"X Li","year":"2023","unstructured":"X. Li, T. Wang, M. Li et al., Comprehensive analysis of BUBs gene family in lung adenocarcinoma with immunological analysis. Aging (Albany NY). 15(3), 810\u2013829 (2023). https:\/\/doi.org\/10.18632\/aging.204517","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1261_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00401-024-02831-w","volume":"148","author":"N Mikolajewicz","year":"2024","unstructured":"N. Mikolajewicz, N. Tatari, J. Wei et al., Functional profiling of murine glioma models highlights targetable immune evasion phenotypes. Acta Neuropathol. 148(1), 74 (2024). https:\/\/doi.org\/10.1007\/s00401-024-02831-w","journal-title":"Acta Neuropathol."},{"issue":"1","key":"1261_CR38","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1186\/s12967-025-07013-0","volume":"23","author":"S Zhou","year":"2025","unstructured":"S. Zhou, L. Xiao, L. Hu et al., CAFs promote immune evasion in gastric cancer through histone lactylation-mediated suppression of NCAPG ubiquitination. J. Transl Med. 23(1), 989 (2025). https:\/\/doi.org\/10.1186\/s12967-025-07013-0","journal-title":"J. Transl Med."},{"key":"1261_CR39","doi-asserted-by":"publisher","first-page":"122392","DOI":"10.1016\/j.biomaterials.2023.122392","volume":"303","author":"Z Qiu","year":"2023","unstructured":"Z. Qiu, Z. Lu, J. Huang et al., Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment. Biomaterials. 303, 122392 (2023). https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122392","journal-title":"Biomaterials"},{"issue":"1","key":"1261_CR40","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41467-021-21828-7","volume":"12","author":"X Wang","year":"2021","unstructured":"X. Wang, J. Wang, Y.M. Tsui et al., RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-beta2. Nat. Commun. 12(1), 1518 (2021). https:\/\/doi.org\/10.1038\/s41467-021-21828-7","journal-title":"Nat. Commun."},{"issue":"10","key":"1261_CR41","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.21873\/anticanres.14540","volume":"40","author":"YM Morillon","year":"2020","unstructured":"Y.M. 2 Morillon nd, A. Sabzevari, J. Schlom et al., The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents. Anticancer Res. 40(10), 5329\u20135341 (2020). https:\/\/doi.org\/10.21873\/anticanres.14540","journal-title":"Anticancer Res."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01261-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01261-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01261-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:55:48Z","timestamp":1791510948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01261-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01261-y","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients signed an informed consent form. The clinical study was approved and reviewed by the ethical approval committee of Harbin Medical University Cancer Hospital and adhered to the tenets of the\n                      Declaration of Helsinki\n                      . The animal study was approved by the Ethics Review Committee of Harbin Medical University Cancer Hospital (approval no. KY2021-15) and complied with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"136"}}